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Plant research and breeding has a long and successful history in the Scan-
dinavian countries, Denmark, Finland, Norway and Sweden. Researchers in
the region have been early in adopting plant gene technologies as they devel-
oped. This review gives a background, as well as discuss the current and future
progress of plant gene technology in these four countries. Country-speciﬁc
details of the regulation of genetically modiﬁed plants are described, as
well as similarities and differences in the approach to regulation of novel
genome-editing techniques. Also, the development of a sustainable bioecon-
omy may encompass the application of plant gene technology and we discuss
whether or not this is reﬂected in current associated national strategies. In
addition, country-speciﬁc information about the opinion of the public and
other stakeholders on plant gene technology is presented, together with a
country-wise political comparison and a discussion of the potential reciprocal
inﬂuence between public opinion and the political process of policy develop-
ment. The Scandinavian region is unique in several aspects, such as climate
and certain agriculturally related regulations, and at the same time the region
is vulnerable to changes in plant breeding investments due to the relatively
small market sizes. It is therefore important to discuss the role and regulation
of innovative solutions in Scandinavian plant research and breeding.
Introduction
Since the development of recombinant nucleic acid tech-
nology and genetic transformation technology in the
1970s, resulting in the ﬁrst genetically modiﬁed (GM)
Abbreviations – AC, Appeal Committee; CJEU, Court of Justice of the European Union; CRISPR, clustered regularly
interspaced short palindromic repeats; EC, European Commission; EEA, European Economic Area; EFSA, European Food
Safety Authority; GM, genetically modiﬁed; GTA, Gene Technology Act (Norway); GTLK, Board of Gene Technology
(Finland); IP, intellectual property; LRF, Federation of Swedish Farmers; NPBT, new plant breeding techniques; ODM,
oligonucleotide-directed mutagenesis; PAFF, Standing Committee on Plants, Animals, Food and Feed; PVY, potato virus Y;
TALEN, transcription activator-like effector nucleases; ZFN, zinc ﬁnger nucleases.
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plant in 1983 (Barton et al. 1983, Herrera-Estrella et al.
1983), gene technologies have been widely applied all
over the world in plant research and breeding. In 2016,
more than 185 million hectares of GM crops were grown
in 26 countries across the world. The top ﬁve countries
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include the United States, Brazil, Argentina, Canada and
India, with the United States contributing with the largest
area of 72.9 million hectares (ISAAA 2016). More recent
techniques for targeted genome editing (GE), including
clustered regularly interspaced short palindromic repeat
(CRISPR)/Cas9 (Lowder et al. 2016, Quetier 2016), tran-
scription activator-like effector nucleases (TALEN) (Pen-
nisi 2012), zinc ﬁnger nucleases (ZFN) (Petolino 2015)
and oligonucleotide-directed mutagenesis (ODM) (Sauer
et al. 2016), are expanding the versatility and efﬁciency
of plant gene technology beyond random recombinant
nucleic acid insertions and are providing researchers
and breeders with an increasing number of options for
trait management. A Web of Science search on ‘plant
genetic modiﬁcation’ and ‘plant genome editing’ gives
an indication of the global uptake of these techniques
in plant research, with a particularly dramatic recent
increase of plant GE research (Fig. 1). However, the com-
mercial application of GM techniques in European plant
breeding has been rather slow, despite the fact that
many European researchers have been at the forefront
of the research in this area. Currently, only one GM
crop is commercially cultivated in the European Union
(EU); an insect-resistant maize (MON810) developed by
Monsanto.
Early recognition of the potential of GM and trans-
formation for plant breeding led to discussions on the
appropriate governance including risk assessment, and
the ﬁrst legislation on the deliberate release into the
environment of GM organisms (GMO) in the EU came
in 1990 with the Council Directive 90/220/EEC. This
Directive contained a legal deﬁnition of GMO and also
listed a number of techniques that are considered to
lead, respectively not lead, to a GMO. Whereas both the
risk assessment and the authorisation decision were from
the beginning in the hands of the EU Member States, a
series of revisions in the late 1990s to early 2000s led
to a more centralised procedure in the EU (Fig. 2). The
European Food Safety Authority (EFSA) was established
to provide an independent and centralised risk assess-
ment, and a much stronger emphasis was put on the
precautionary principle in the legislation for cultivation
of GM crops (Directive 2001/18/EC, Ofﬁcial Journal of
the European Communities 2001) and for food and feed
applications (Regulation 1829/2003, Ofﬁcial Journal of
the European Communities 2003). Labelling and trace-
ability requirements were also established through Regu-
lation 1830/2003 (Ofﬁcial Journal of the EuropeanUnion
2003). There is considerable inherent tension in the
GMO governance framework though, and Casacuberta
et al. (2017) have listed a number of contentious issues
between actors and values in the GMO risk assessment
and management, including (1) the balance between the
EU centralised power andMember States, (2) the balance
between consistency and the case-by-case approach and
(3) the difﬁculty of dealing with uncertainty in the risk
assessment, which is carried out by scientiﬁc experts,
while at the same time deliver a clear message on the
risk to risk managers.
Similar to the EU GMO Directives and Regulations,
the regulatory system in Norway, is based upon the
OECD Guidelines (1986). The Norwegian Gene Tech-
nology Act (GTA) of 1993 (Genteknologiloven) regu-
lates the production and use of GM microorganisms,
plants and animals, where the organisms are modiﬁed
using gene or cell technology. Under the negotiations
of the European Economic Area (EEA) Agreement (1995)
between the EU and the EFTA countries, Norway became
afﬁliated with the EU GMO authorisation process, but
negotiated to maintain three additional requirements in
the aims of the GTA. In addition, Norway also regulates
GM in food and feed applications through the Food Act
(Matloven) of 2003. As in the EU, any GM approved
ingredient in food and feed exceeding 0.9% must be
labelled.
With the advent of the highly efﬁcient and versatile
GE techniques, a discussion on how these should be
regulated has surged in the last few years. A large part
of the scientiﬁc literature, as well as position statements
from EU agencies, Member State national competent
authorities and international organisations agree that the
GMO deﬁnition of Directive 2001/18/EC is not straight-
forward applicable to these techniques (for reviews, see
Sprink et al. 2016, Wolt et al. 2016, Hartung and Schie-
mann 2014, Lusser and Davies 2013, HLG-SAM 2017,
EASAC 2017). However, the European Commission (EC)
has so far not provided any legal guidance for these
techniques and their derived products, which currently
makes the progress of plant research and breeding in the
EU unpredictable and complicates long-term planning.
Plant research and breeding has a long and successful
history in the Scandinavian countries (for an overview of,
e.g. potato breeding in Sweden, Norway and Finland, see
Eriksson et al. 2016). Research on plant biotechnology
is carried out at many of the region’s largest universities
and research institutes and a number of internationally
recognised plant research centres and networks have
been established, including in Sweden: PlantLink (www
.plantlink.se), Umeå Plant Science Centre (www.upsc
.se) and Linnean Centre for Plant Biology (www.lcpu.se);
in Denmark: Copenhagen Plant Science Centre (www
.cpsc.ku.dk) and in Norway: the National Network for
Plant Biology Research in Norway (www.plantnorway
.com). This review provides a timely overview of the
applications and the respective national policies and
positions for plant gene technology in the Scandinavian
220 Physiol. Plant. 162, 2018
Fig. 1. Web of Science search for plant research using genetic modiﬁcation (GM) or genome editing, 20/5/17. Search string for GM: (plant OR crop)
AND ((genet* AND modiﬁ*) OR transgen*), search string for genome editing: (plant OR crop) AND ((gen* AND edit*) OR (target* AND mutagen*)
OR CRISPR* OR TALE* OR ZFN OR meganucleas* OR SDN OR ODM OR (oligo* AND mutagen*)).
region. We will also discuss whether or not national
policies on plant gene technology are compatible with
other national strategies related to various aspects of
sustainable development, as well as do country-wise
comparisons against a European background.
Plant gene technology ﬁeld applications
in the Scandinavian countries
Many plant researchers and breeders in the Scandina-
vian countries have been early in adopting gene tech-
nologies in their work. This has resulted in a large num-
ber of experimental GM plant trials both for contained
use in greenhouse facilities and ﬁeld release, and sev-
eral platforms for the application of plant GE have been
established, though there are some differences among
the countries. It is beyond the scope of this article to
list all contained GM or GE experiments that have been
carried out in the region, however, presented below is a
comprehensive overview of plant gene technology ﬁeld
research applications to date. There is currently no com-
mercial GM crop cultivation in any of the Scandinavian
countries, mainly because the speciﬁc crop-trait combi-
nation (i.e. maize with Bt-conferred insect resistance) of
the only ﬁeld crop GM event currently authorised for
commercial ﬁeld release in the EU is not of interest to
the Scandinavian farmers.
In Denmark the ﬁrst GM crops, namely glyphosate-
tolerant sugar beet and fodder beet, were developed in
the late 1980s and early 1990s by Maribo Seed, Danisco
Seed and DLF-Trifolium A/S. These crops were tested
in ﬁeld trials in several different locations in Denmark
between 1990–1999. Additionally, ﬁeld trials were
also conducted with glyphosate-tolerant oilseed rape
developed by Aventis (now Bayer A/S) and potatoes
with altered carbohydrate composition in the tubers or
with resistance to virus (Madsen et al. 2001). A total
of 38 notiﬁcations for ﬁeld trials were approved during
this period (European Commission 2012b). However,
in 2001, the EU placed a ‘de facto moratorium’ on
approvals of GMOs (Library of Congress 2015a). Some
Member States, including Denmark, therefore agreed to
vote against any new GM approvals until an improved
regulation was implemented in EU. This reduced the
number of ﬁeld trial notiﬁcations in Denmark to zero in
2000–2004. In the following 8 years (2005–2011) there
were a total of 16 GM ﬁeld trial notiﬁcations, some of
which were tested in multiple locations (Figs 3 and 4;
Table 1A). Two notiﬁcations were from theDanish breed-
ing company DLF-Trifolium (glyphosate-tolerant fodder
beet, ryegrass with increased leaf fructan) and 2 from
the Danish biotechnology company Aresa (thale cress
for explosive landmine discovery), while 10 were from
Monsanto (glyphosate-tolerant maize NK 603 and sugar
beet H7-1) and 2 from Syngenta (glyphosate-tolerant
maize GA21). In 2012–2016 there has only been one
notiﬁcation; a 50m2 ﬁeld trial with cisgenic barley
having increased phytase activity in the mature grain,
conducted by Aarhus University in 2012–2013 (Holme
et al. 2012). However, since some of the previous notiﬁ-
cations were approved for 5 years, there were ﬁeld trials
still going on during 2012 from Monsanto originating
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Fig. 2. The GMO authorization procedure in the European Union (A) and Norway (B). (B) The Norwegian evaluation process goes in parallel with EU.
The Norwegian Environment Agency distributes the application to the agencies/authorities, which assess the application due to their responsibilities
and gives their input to The Norwegian Environment Agency during the EU consultation period. If VKM consider that EFSAs risk assessment (after the
consultation period) is not good enough or relevant for Norwegian conditions, VKM perform a new assessment (health and environment) based
on EFSAs report, but with focus on conditions relevant for Norway. The other agencies use this report in their ﬁnal report to The Norwegian
Environment Agency. The Ministry of Climate and Environment (MCE) makes their decision after assessment of The Norwegian Environment Agency’s
recommendations shortly after the EU decision. Applications under the Food Act is coordinated and evaluated by the Norwegian Food Safety Authority.
Notes: 1) Reg 1829/2003 is not implemented in the EEA agreement or Norwegian law, so applications under this regulation are not processed according
to the new procedures valid for applications under Dir 2001/18/EC shown in the ﬁgure. Applications under this regulation are coordinated by the
Norwegian Environment Agency (living GMOs) and the Norwegian Food Safety Authority (processed GM food and feed), respectively. The agencies
assess the application and give their input to EFSA in the ﬁrst round in parallel with the process in EU. However, the main assessment takes place
after the decision in EU, although decisions are put on hold until the Regulation is implemented in Norwegian law. 2) A GMO that fails to receive
authorization in the EU is similarly not authorised in Norway, whereas an EU-approved GMO is authorised in Norway unless the MCE/Government
decides to ban it.
from the notiﬁcations on maize in 2008 and in 2009
and from the notiﬁcations on maize and sugar beet in
2011. However, in 2013 before the growing season, all
ﬁeld trials from Monsanto in Denmark were stopped
due to poor experimental results with both maize and
sugar beet and because of the resistance against GM
plants from the Danish public. There have been no
notiﬁcations of ﬁeld trials from 2013 until now and there
have been no GM ﬁeld trials in Denmark since 2014.
In Finland, GM applications for crop improvement
started in collaboration with the Kemira Oy company in
late 1980s, focusing on potato, birch, gerbera (Elomaa
et al. 1993) and petunia (Helariutta et al. 1993). With the
aim to start a public discussion on the topic, transgenic
potatoes were grown in the Kemira Kotkaniemi research
station in 1988 and birch in 1990–1991 (Häggman et al.
1997). A press release was prepared and journalists were
invited to the ﬁeld sites, but the experiments did not
attract any interest. In 1992–1993 a ‘ﬁeld trial for com-
mercialization’ (in practice the plants were grown on
the yards and balconies of the researchers) was done
with bright orange petunia lines expressing the gerbera
DFR gene. The aim was not to commercialise these
plants, e.g. the intellectual property (IP) rights concern-
ing the method and vector parts were not solved, but
rather to test the procedure of conducting a ﬁeld trial
as any GMO legislation was not yet in effect. By the
appeal of researchers, the National Board of Health
had nominated a Recombinant DNA Expert Group who
gave statements and issued guidelines about the safety
of recombinant DNA technology including ﬁeld exper-
iments. Later, a similar role was adopted temporarily by
the Advisory Board on Biotechnology, and there were
efforts to introduce the regulation of GMOs to the law
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Fig. 3. Number of GMO ﬁeld trials per year between 1995–2016 in
Denmark, Finland and Sweden. Field trials conducted in Denmark in
1990–1999 (38 notiﬁcations) are not included as information about the
exact areas is not available. For Finland, the actual number of permits,
rather than ﬁeld trials, are presented. Field trials conducted in Sweden
in 1995–1996 (four notiﬁcations) are not included as information about
the exact areas is not available (nor for previous since 1989).
on infectious diseases, however, without success. In
practice, the compliance with the guidelines remained
voluntary (Matti Sarvas, personal communication). Since
1995, a total of 20 GM plant ﬁeld trials have been autho-
rised in Finland (Fig. 3) corresponding to a rather modest
area of approximately seven hectares (Board for Gene
Technology 2017) (Fig. 4, Table 1B). The ﬁrst trials that
were ﬁled under the Gene Technology Act (377/1995)
were conducted by The Finnish Forest Research Institute,
Punkaharju Research Station with Norway spruce, silver
birch and Scots pine in 1996–1998 (Häggman et al.
1997, Aronen et al. 1998, 2003) as well as by Mildola
Oy with high-stearic acid oilseed rape in 1995–1998.
Transgenic barley and potato were also among the ﬁrst
GM ﬁeld trials. Boreal Plant Breeding Ltd. carried out
the barley experiments in 1996 and 1997 with trans-
genic material carrying the npt2 marker gene (Ritala
et al. 1994) with the aim to evaluate possibilities of
pollen-mediated gene ﬂow in a self-pollinated species
(Ritala et al. 2002). The GM potato trials, performed by
University of Helsinki, dealt with potato virus Y (PVY)
Fig. 4. Total area (hectare) per year of GMO ﬁeld trials between
1995–2016 in Denmark, Finland and Sweden. Field trials conducted
in Denmark in 1990–1999 (38 notiﬁcations) are not included as infor-
mation about the exact areas is not available. Field trials conducted in
Sweden in 1995–1997 (nine notiﬁcations) are not included as informa-
tion about the exact areas is not available (nor for previous since 1989).
resistance via sense and antisense orientation of P1
encoding gene from PVY O-strain (Maki-Valkama et al.
2000, Maki-Valkama et al. 2001). The latest authoriza-
tion for a ﬁeld trial was obtained in 2013 for hybrid
aspen, with the University of Helsinki evaluating trans-
genic traits involved in softwood characteristics and
growth in 2013–2018. After that no applications have
been ﬁled for GM ﬁeld trials permits.
Norway’s ﬁrst GM ﬁeld trial was carried out by NTNU
in Trondheim with potato containing only marker genes.
It took place on the grounds of Kvithamar Research Sta-
tion in 1991 and lead to a report commissioned from
the Norwegian authorities on risk assessment of GM
potato in Norway (Rognli and Potter 1991). As men-
tioned above, the current GTA was in place in Norway
in 1993, and the ﬁrst application of deliberate release
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Table 1. Area (hectare) cultivated with genetically modiﬁed (GM) crops in Denmark (A), Finland (B) and Sweden (C), breakdown per crop. Field
trials with Arabidopsis thaliana are not presented. (A) Denmark 2005–2013. Field trials from 1990–1999 (38 notiﬁcations) are not included as
information about the exact areas is not available. No GM cultivation took place 2014–2016. Source: http://gmoinfo.jrc.ec.europa.eu/overview/dk
.asp. (B) Finland 1995–2013. No GM cultivation took place 2014–2016. Source: http://geenitekniikanlautakunta.ﬁ/en/deliberate-release/authorised-
ﬁeld-trials. (C) Sweden 1998–2016. Source: http://www.jordbruksverket.se/amnesomraden/odling/genteknikgmo/faltforsok/genomfordaforsok.4
.300b18bd13d103e79ef80002619.html
A. Denmark
Year Barley Fodder beet Maize Ryegrass Sugar beet
2005 5.0
2006 0.0056
2007 8.0 0.0056
2008 10.05 0.0056
2009 11.75
2010 10.0
2011 12.0 2.0
2012 0.005 4.0 2.0
2013 0.005
Total 0.01 5.0 55.8 0.0168 4.0
B. Finland
Year Barley Birch Hybrid Aspen Norway spruce Oilseed rape Potato Scots pine Sugar beet Tobacco
1995 0.11
1996 0.0225 0.021 0.7 0.2 2.4
1997 0.2 0.03 0.12
1998 0.4
1999 0.3 0.5
2000 0.22, 0.04
2001 0.0049
2002
2003
2004 0.06
2005 0.1
2006
2007
2008
2009 0.1
2010 1.0
2011
2012
2013 0.2
Total 0.2225 0.221 0.2 0.7 0.11 1.2949 2.4 0.82 0.5
C. Sweden
Year Apple Barley Crambe abyssinica Flax Hybrid Aspen Maize Oilseed rape Potato Sugar beet Turnip rape
1998 5.9 350 1.3 0.8
1999 7.4 390 4.6
2000 9.6 170 2.4
2001 0.012 8.5 4.3 0.2
2002 0.037 5.5 9.6 0.08
2003 0.037 7.3 9.1 0.2
2004 0.037 0.001 8.8 4.9 0.046
2005 0.2 0.048 9.6 16.0 0.5
2006 0.2 0.3 12 68.0
2007 0.2 0.002 0.4 1.2 54.0
2008 0.2 0.004 1.2 1 78.0 0.4
2009 0.2 0.003 1.3 2.7 62.0 0.8
2010 1.6 2.0 1.4 11.0
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Table 1. Continued
C. Sweden
Year Apple Barley Crambe abyssinica Flax Hybrid Aspen Maize Oilseed rape Potato Sugar beet Turnip rape
2011 1.6 3.2 11.6 0.43
2012 1.6 0.073 0.2 3.5 0.35 1.26
2013 1.6 0.1 3.5 0.01
2014 1.6 0.4 5.7 0.075
2015 1.6 0.4 5.7 1.0
2016 1.6 0.5 6.4 0.7
Total 12 323 0.073 1.6 0.048 30.01 4.6 79.5 1240.6 12 216 0.8
of a GMO under this new regulation was an antisense
construct of ACC synthase from squash into Christmas
begonia to increase the keeping quality (Hvoslef-Eide
et al. 1995). This deliberate release permit was given
for 5 years in the greenhouses of the Agricultural Uni-
versity of Norway (the present Norwegian University of
Life Sciences). According to the European Commission’s
GMO register (European Commission 2012c), only one
application for deliberate ﬁeld release (ﬁeld trial) has
been notiﬁed from Norway in the entire period from
1999–2017. This application from University of Tromsø
concerned GM European aspen (European Commission
2012a). There are no commercial breeding companies
in Norway that use GM or GE technology in the breed-
ing process. However, the Norwegian breeding com-
pany Graminor with research partners (NMBU, NIBIO,
UiO, Høyskolen i Hedmark) is using GE technology
in research to evaluate gene functions in crops; e.g.
potato, raspberry and strawberry. [Correction added on
28 November 2017, after ﬁrst online publication: The
sentence has been updated.] As of today, no food or
feed is authorised for sale on the Norwegian market and
no GM ﬁeld crops have been authorised for commercial
cultivation, whereas only a number of purple carnations
have been authorised for import through the EEA Agree-
ment (Table 2).
Sweden is the only Scandinavian country, which is
currently harbouring ﬁeld trials with GM plants, and in
terms of both numbers and total area it has also carried
out by far the largest amount (Figs 3, 4). GM crops were
grown in ﬁeld trials for the ﬁrst time in 1989, and the
major GM crop under ﬁeld-testing has been potato,
particularly with three consecutive years in 1998–2000
with very large areas (Fig. 4, Table 1C). In the early years
(1989–1996), ﬁeld-testing was carried out with GM
oilseed rape, turnip rape, potato and sugar beet. GM
ﬁeld testing has been carried out both by public research
institutes such as the Swedish University of Agricultural
Sciences (SLU) and Umeå University (UU), private
companies such as SweTree Technologies AB (SweTree),
Plant Science Sweden, Monsanto, Syngenta, Hilleshög
AB, Svalöf Weibull AB, Amylogene and Plant Genetic
Systems N.V./Aventis CropScience Nordic A/S, and
farmers’ associations such as Sveriges Frö- och Oljeväx-
todlare. A list of GM trees and crops cultivated in the
ﬁelds in Sweden in 1998–2016 and the targeted traits are
presented below and the available corresponding areas
in Table 1C. Transgenic apple (Malus domestica) and
Table 2. GM approvals in Norway to date. EEA, European Economic Area.
Event Applications in the EEA Modiﬁed trait Approved in the EEA
Carnation
‘Moonlite’
123.2.38
Ornamental plant Changed ﬂower colour 23/5/07
Carnation
‘Moonaqua’
123.8.12
Ornamental plant Changed ﬂower colour 16/3/09
Carnation
‘Moonvelvet’
IFD-26407-2
Ornamental plant Changed ﬂower colour 24/4/15
Carnation
‘Moonberry’
IFD-25958-3
Ornamental plant Changed ﬂower colour 24/4/15
Carnation
SHD-27531-4
Ornamental plant Changed ﬂower colour 22/11/16
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pear (Pyrus communis) rootstocks have been ﬁeld tested
to evaluate the rooting ability of the transgenic rootstocks
and to evaluate the non-transgenic cultivars of apple or
pear grafted onto them for growth, ﬂowering and fruit
quality evaluation. Transgenic barley with improved
nitrogen efﬁciency was tested in a small trial in 2012.
Transgenic crambe (Crambe abyssinica) has been tested
in the ﬁelds for improving the overall oil content in the
seeds and for evaluating the levels of erucic acid, C22
alcohol and fatty acids or C44 wax esters in the seed oil.
Transgenic ﬂax with altered seed oil composition was
tested in a small trial in 2005. Transgenic hybrid aspen
lines (Populus tremula x Populus tremuloides) have been
tested in the ﬁelds for (1) wood quality; (2) increased
growth in the ﬁeld; (3) autumn phenology traits and
(4) increased wood biomass by increased growth or
improved drought tolerance. Transgenic maize with
tolerance to the herbicide glyphosate has been tested
in the ﬁeld during ﬁve consecutive years (2006–2010).
Transgenic oilseed rape has been tested for (1) improved
seed oil content and quality; (2) modiﬁed storage pro-
teins; (3) male sterility for hybrid production and (4)
herbicide (Basta) tolerance. Transgenic potato (Solanum
tuberosum) lines have been cultivated in the ﬁelds for
(1) evaluating resistance to Phytophthora infestans;
(2) potato starch with increased levels of amylose;
(3) increased amylose content and improved starch
biosynthesis; (4) increased starch amylopectin content
and (5) increased amylose and oil content. Transgenic
sugar beet (Beta vulgaris) was cultivated in the ﬁelds for
evaluating (1) tolerance to the herbicide glyphosate; (2)
resistance to rhizomania and (3) tolerance to glyphosate
and resistance to rhizomania. Finally, transgenic turnip
rape with tolerance to the herbicide Basta was tested in
1998. In 2017, ﬁeld-testing is ongoing or planned for
the following GM plants: hybrid aspen (UU, SLU, Swe-
Tree), Crambe abyssinica (SLU), potato (SLU), Lepidium
campestre (SLU), Camelina sativa (SLU), and apple and
pear (SLU) (Swedish Board of Agriculture 2017). In 2010
and 2011, commercial production of a GM potato with
modiﬁed starch quality took place in Sweden following
EU authorization; however, this GM event has since
been withdrawn from the market.
When comparing the four countries, it is clear that
Sweden has carried out most GM plant ﬁeld trials over
the years. We can only speculate about the reasons for
this, but it seems as if more companies that have been
active in Sweden have been prone to adopt gene tech-
nologies in their research and development (R&D) activ-
ities. Swedish universities has also been active in carrying
out GM plant ﬁeld trials, and this may be the reason
why Sweden is the only country in Scandinavia which
keep carrying out these ﬁeld trials. Around 2011–2012,
there was a general trend in the EU for seed companies to
terminate their R&D activities involving GM technology
due to the lack of progress in the authorization process.
This is reﬂected in the decrease in number of notiﬁca-
tions for ﬁeld trials in the EU observed from 2013 to 2017
where there was an average of only 12.6 notiﬁcation per
year whereas the average number were 123 notiﬁcations
per year from 1991 to 2012. This trend seems to have
affected not the least Denmark, over the entire described
period Figs 3 and 4 do not give the complete picture
for Denmark, as the ﬁeld trials from 1990 to 1999 are
not included because the information about the areas is
not available. Finland has had a very modest ﬁeld trial
activity over the years, whereas Norway, which is not
included in Figs 3 and 4 due to the almost complete
absence of GM plant ﬁeld trials, has often experienced
a relatively strong political opposition to the application
of plant gene technologies and this may explain the lack
of either private or public ﬁeld trials.
Given the lack of EU regulatory guidance and the
relatively permissive position (for certain applications)
taken by some of the Scandinavian countries (see below),
it is currently not known whether or not any ﬁeld
trials with GE plants have been carried out in any
Scandinavian country. In November 2015, two Swedish
research groups received ofﬁcial clearance from the
Swedish Board of Agriculture that ﬁeld release of their
CRISPR-modiﬁed Arabidopsis lines would not require
the permission normally requested for GMO ﬁeld tri-
als (Swedish Board of Agriculture 2015), and in May
2016 a research group at the University of Turku, Finland,
received a similar clearance from the Board of Gene
Technology (GTLK) for CRISPR-modiﬁed Arabidopsis.
However, it is not known whether or not these Arabidop-
sis lines have been cultivated in the ﬁeld. Therefore, to
date, the only known case of open air cultivation of a
GE plant in the region is when a Swedish researcher in
2016 cultivated CRISPR-modiﬁed cabbage in a small gar-
den plot, which was publicly announced by serving a
meal to a journalist (Cohen 2016). There are also other
Swedish research examples of GE crop plants that are in
the pipeline for ﬁeld-testing, given regulatory clearance
(Nicolia et al. 2015, Andersson et al. 2017).
Plant gene technology policies in the
Scandinavian countries
The use of GM technology in plant research and breeding
in the EU Member States Denmark, Finland and Swe-
den is regulated through the national implementation
of a number of EU Directives as well as direct appli-
cation of relevant EU Regulations, and also Norway,
which is not a EU Member State (only EEA afﬁliated),
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has regulations based on the EU framework. There are
nevertheless differences among the Scandinavian coun-
tries, both regarding the details of implementation and
the approach to policy developments.
One overall law regulates the use of gene technology
in Denmark: Law on environment and gene technology.
This law corresponds to the Danish implementation of
the EU Directive 2001/18/EC on deliberate release of
GMOs and the EU Directive 2009/41/EC on contained
use of GM microorganisms. The Law on environment
and gene technology is attached with a range of instruc-
tions, such as approval on production with GM plants
and animals and on relevant fees. In addition, Denmark
was the ﬁrst of the Scandinavian countries to make (1)
coexistence rules for GM crops in relation to conven-
tional and organic crops and (2) a law on coexistence
that came into force in 2005 (Tolstrup et al. 2003, 2007).
The law contains two executive orders, one on cultiva-
tion of GM crops (deﬁning isolation distances, cropping
intervals, control of volunteer plants, cleaning of machin-
ery and transportation measures) and the other, which is
unique to Denmark, on compensation to neighbouring
farmers in case of economic loss due to GM admixture.
Also, GM farmers and GM handlers need a licence for
certain education requirements within the ﬁeld of co-
existence in order to perform the growing, handling and
transport of GM crops. Additionally, the law describes
the rules for providing information to neighbours and
the public about the location of the GM ﬁelds. If an un-
intended spread of GM material to conventional or
organic neighbouring ﬁelds should happen, the farmers
will get compensation. The money will be ﬁnanced by a
fund into which farmers pays 100DKK per hectare grown
with GM crops. The Danish voting behaviour regarding
authorization of GM plants is not exclusively following
the advices given by EFSA and national experts. After
the Directive (EU) 2015/412 on the possibility for EU
Member States to restrict or prohibit the cultivation of
GMOs in their territory (Council Directive 2015), there
are examples where political majorities in the Danish
parliament have stopped the approval of GM plants for
the Danish market although EFSA and national experts
have evaluated that the crops can be grown in Den-
mark without risk. In a prominent example just after
the Directive (EU) 2015/412 was adopted, by a major-
ity overruling the Minister of Environment and Food
stopped four GMmaize cultivars. Regarding the legal sta-
tus of new plant breeding techniques, no special adapted
policies covering these rapidly developing technologies
have so far been developed. Policies are under devel-
opment and national experts and stakeholders are dis-
cussing potential beneﬁts and regulations of these new
technologies.
In Finland, the use of GMOs is regulated by Gene
Technology Act (377/1995) and the Board of Gene
Technology (GTLK) is the competent authority. The
Gene Technology Act is based on the EU Directives
2001/18/EC and 2009/41/EC. The Gene Technology Act
pertains also to the contained use of GM plants and ani-
mals, thus differing from the latter Directive. The Gene
Technology Act has been supplemented by Government
Decrees. The statutes have been amended several times
after the year 1995. The following are the main statutes
related to deliberate release of GM plants in force at
present: (1) Government Decree on Gene Technology
(928/2004), (2) Decree of the Ministry of Social Affairs
and Health on the deliberate release of genetically mod-
iﬁed organisms (110/2005), (3) Decree of the Ministry of
Social Affairs and Health on the differentiated procedure
relating to the deliberate release of genetically modiﬁed
organisms (90/2005), (4) Decree of the Ministry of Social
Affairs and Health on Inspection Procedures under the
Gene Technology Act (198/2007) and (5) Government
Decree on Chargeable Performances under the Gene
Technology Act (1158/2009). Regarding GE plants, in
November 2013 the US-based company Cibus sent a
letter to GTLK to ask if oilseed rape bred with ODM falls
under the category of gene technology regulations in
Finland. GTLK replied in January 2014 that the use of the
ODM-based Rapid Trait Development System (RTDS™)
proprietary technology of Cibus does not fall under
the scope of Directive 200l/l8/EC and thus the ﬁeld
evaluations of the aforementioned plants would not be
subjected to the notiﬁcation procedure of the Gene Tech-
nology Act (37711995). However, GTLK reminded that
if changes in EC regulation take place the Board reserves
the right to reconsider their statement (Board for Gene
Technology 2017). Similarly in 2016, the University of
Turku asked GTLK if CRISPR/Cas9-edited Arabidopsis
plants are subject to the gene technology law and statutes
in Finland. The interim decision of GTLK on 19 May
2016, valid only for the requested Arabidopsis plants,
was that they are not. However, GTLK requested that
prior to possible ﬁeld trials, the University of Turku needs
to deliver conﬁrmation with whole-genome sequencing
that the plants do not contain any foreign DNA.
In Norway, the development and use of living GMOs
(including seeds) is regulated by the GTA (Klima- og
miljødepartementet 2015b), while processed food and
feed containing GM ingredients is regulated by the Food
Act (Fig. 2). Directive 2001/18/EC on deliberate release
into the environment of GMOs is incorporated into the
EEA Agreement, and thus Norway is afﬁliated with the
EU GMO approval procedures. According to §10 of
the GTA, GMOs approved in the EU under Directive
2001/18/EC are also authorised in Norway and do not
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need a speciﬁc Norwegian approval; however, they can
be prohibited if they contravene the criteria of the GTA.
In addition to be safe for the environment and human
health, GMOs should be in accordance with societal
beneﬁts, promote a sustainable development and be
ethically justiﬁable (Hvoslef-Eide 1995, 2012). Norway
has been granted these additional requirements under
the EEA agreement provided the EU does not suspect that
Norway uses this as a hidden trade barrier. Through its
EEA agreement, Norway is an observer in the committees
of the GMO decision process in EU, but has no voting
rights. According to the GTA, an independent (but gov-
ernmentally appointed) Biotechnology Advisory Board
will evaluate and make statements on GMO matters reg-
ulated by the law. The board has no approval authority,
but gives advice to the Government with speciﬁc focus
on the societal beneﬁt, sustainability and ethics criteria
of the GTA. In general, the majority of the members vote
against recommendation of approval of GMO applica-
tions. Until recently, there has been an interpretation of
the Gene Technology Act that all GMO approvals in any
EU Member State under Directive 2001/18/EC that had
not yet been evaluated by Norwegian authorities were
prohibited. However, in 2014 the Ministry of Climate
and Environment declared that nine EU-approved GMOs
were authorised in Norway according to the Directive
(Klima- og miljødepartementet 2015a), because they
had not been actively prohibited according to the
law. On 2 June 2017, the Norwegian government pro-
hibited import of four of these GMOs (three oilseed
rape events and one maize event), while ﬁve cultivars
of carnations were approved (Table 2). The maize event
1507 was prohibited because it was considered to not be
ethically justiﬁable as it contains genes for tolerance to
glufosinate-ammonium, which is not authorised for use
in Norway. Norway has through GTA regulations prohib-
ited another six GMO events approved in the EU under
Directive 2001/18/EC (Klima- og miljødepartementet
2000). On 5 July 2017, the Ministry of Climate and
Environment established new efﬁcient procedures for
the evaluation of GMO applications under Directive
2001/18/EC that replaced an elaborate two-step evalu-
ation process (before and after EU approval). The main
part of the Norwegian evaluation will now take part
in parallel with the EU evaluation, which secure that
Norwegian authorities can take a decision according to
the GTA shortly after EU approval, and not after a new
round of evaluations as before (Norwegian Ministry of
Climate and Environment 2017). Since Norway already,
through the EEA agreement and its adaption to the
Directive 2001/18/EC, is allowed to restrict or prohibit
distribution and growth of GMO on criteria such as
societal beneﬁts, sustainable development and ethics
in addition to health and environment, the Ministry of
Climate and Environment do not see any need to change
the law to implement Directive (EU) 2015/412.
In contrast to Directive 2001/18/EC, Regulation (EC)
No 1829/2003 (Council Regulation 2003) on GM food
and feed is not incorporated into the Norway-EEA agree-
ment. However, Norwegian authorities still evaluate the
applications in a two-step process, where the Norwe-
gian Environment Agency is responsible for evaluating
living GMOs under the GTA and the Norwegian Food
Safety Authority is responsible for evaluating processed
food and feed produced from GMO under the Food Act
(Fig. 2). Since the two authorities evaluate GMOs under
two different acts with different evaluation criteria (only
health, coexistence and environment for the Food Act,
and in addition ethics, beneﬁt for society and sustainabil-
ity for the GTA) they can come to different conclusions.
However, since the regulation is not included in the EEA
agreement, Norway will not give any ﬁnal decision on
any GMO or processed product from this GMO even
after the risk assessment has concluded that it is safe.
Norway has decided to process all the applications under
Regulation No 1829/2003/EC even though this Regula-
tion is not yet included in the EEA agreement. This entails
that there will be a portfolio of EU-approved applications
that are processed after Norwegian law ready for the
Government to decide once the agreement is in place.
Another consequence of the regulation not being part
of the EEA Agreement is that living GMOs with expired
authorization under Directive 2001/18/EC in EU (and
Norway), but with renewed authorization under Regula-
tion No 1829/2003/EC, are not automatically authorised
in Norway. To get a formal authorization for marketing
processed food and feed produced from GMO in Nor-
way, a separate application under the Food Act (Fig. 2)
is required even if the product is already approved in
the EU. However, since the market is so small, very few
companies do this, and there has been none the last
10–15 years. Living GMOs and processed food and feed
products produced from GMOs with functional anti-
biotic resistance genes that can be identiﬁed by analysis
are prohibited by the Food Act. The regulation of pro-
cessed food and feed containing GMO was included in
the Food Act in 2005 to harmonise with the EU regu-
lations from 2003. Until then, GM feed did not require
any speciﬁc approval. As an interim arrangement, GM
feed notiﬁed by the industry that had been used in
Norway until the new regulations, and that already was
approved in EU, could be exempted from the approval
requirements for 3 years. The interim arrangement ended
in 2008, and the Norwegian Seafood Federation has
each year applied for exemption from the require-
ments to apply for approval of GM ﬁsh feed from the
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Norwegian Food Safety Authority for 19 GM products
(Mattilsynet 2013, 2014). Until 2013 they got an exemp-
tion each year, however, in 2014 the application was
declined because the industry never took advantage of
the possibility to use GM feed.
In Sweden, the EU Directive 2001/18/EC is imple-
mentedmainly through the Swedish Environmental Code
(1998) as well as by the Regulation 2002:1086 on delib-
erate release of GMOs to the environment, whereas the
Regulation 2000:271 on contained use of GMOs is spe-
ciﬁc to Sweden (as in Finland) in the sense that only
the contained use of GM microorganisms is regulated in
the EU whereas Sweden also includes GM plants in this
Regulation. EU Regulations, such as No 1829/2003/EC,
No 1830/2003/EC and No 1946/2003/EC, are directly
applicable in all EU countries including Sweden. Direc-
tive (EU) 2015/412 on the possibility for the EU Member
States to restrict or prohibit the cultivation of GMOs in
their territory has not been implemented in the Swedish
legislation; however, a Swedish Government Ofﬁcial
Report suggested that the Swedish Environmental Code
could potentially be amended to implement this Direc-
tive, even though the report could not predict that it
would be relevant for any crop or trait in the fore-
seeable future (SOU 2016:22). Since 1994, the Gene
Technology Advisory Board (Gentekniknämnden), with
seven experts and one representative from each politi-
cal party in the Swedish parliament, has been provid-
ing non-binding advice to the Swedish Government on
the use of gene technology. Regarding the legal status
of new plant breeding techniques (NPBT), and partic-
ularly GE, the Swedish Government and the Swedish
Board of Agriculture have on several occasions ofﬁcially
supported the position that a product needs to con-
tain detectable recombinant nucleic acid sequences in
order for it to be deﬁned as a GMO according to the
deﬁnitions contained within Directives 2001/18/EC and
2009/41/EC. In November 2015, the Board of Agricul-
ture assessed that, according to current legislation, a
CRISPR/Cas9-mutated Arabidopsis should not be sub-
ject to the GMO regulatory process under the condition
that it does not contain foreign DNA (Swedish Board
of Agriculture 2015), which was followed by a letter
from the Swedish Ministry of Enterprise and Innovation
to the EC Directorate General Health and Food Safety
(DG-SANTE) emphasising that the legal framework in
the EU for GMO is not appropriate for handling some
of the new GE techniques (Swedish Ministry of Enter-
prise and Innovation 2016). A similar stance as in Fin-
land was taken to the request from the company Cibus
whether or not ﬁeld release of an ODM-modiﬁed oilseed
rape needed permission according to the GMO regula-
tion (Fladung 2016). The Swedish position on GE was
reinforced in January 2017 in a written opinion referred
to the Court of Justice of the European Union (CJEU)
regarding the request from the French High Court to the
CJEU to clarify the legal status of GE techniques (Con-
seil D’État 2016). The Swedish position argued that GE
resulting in targeted mutagenesis including less than the
technical detection limit of 20 nucleotides should not be
considered GMO whereas GE resulting in targeted inser-
tion of more than 20 nucleotides should be considered
GMO (Swedish Ministry of Foreign Affairs 2017).
Several countries around the world seem to take more
or less the same stand on GE as Sweden has indicated,
including in the EU; Finland and the Netherlands (the
Netherlands Government 2017) and outside of the EU;
Argentina (Whelan and Lema 2015), Canada (Smyth
2017) and the United States (Ledford 2016), where the
authorities have decided not to regulate GE in the same
way as GM, or do so on a case-by-case basis. Australia
and New Zealand have a coordinated regulatory frame-
work and they have come to the opposite conclusion:
to regulate GE as they regulate GM (Logan 2017; Mac-
Manus 2017). The rest of the world, including the two
large agriculture-producing countries Russia and China,
as well as the EU, have yet not decided how to deal with
the emerging GE technologies.
In an EU context, the occasional positions taken by the
governments of Finland and Sweden on plant GE appli-
cations are interesting as they to some extent adhere to
a product-based interpretation of the EU GMO Direc-
tives in the sense that an organism should contain, and
not only have been developed by the use of, recombi-
nant nucleic acids in order to be classiﬁed as a GMO.
We have so far not seen any ofﬁcial position from Den-
mark, nor from Norway, on this matter; however, it will
be very interesting to follow the imminent developments
in the EU regarding GE and other new plant breeding
techniques (NPBTs) and how the Scandinavian EUMem-
ber States position themselves.
Whether a GE plant is considered under the current
legislation on GM or not has wide economic implica-
tions for small and medium-size breeding companies in
Europe and, as a consequence, also for our farmers. The
GM regulations place heavy economic burdens on the
product, and only the economically strong multinational
companies can afford to pay the price of getting a GM
variety or a GM-derived product to the market. This is
the unintentional effect of strict regulations. Using GE
technologies, where no foreign DNA is added, has been
considered by several authorities to be similar enough to
conventional breeding to not be subject to the same risk
assessment as GMOs. If this position is adopted by EU,
it will empower small and medium-size breeding com-
panies, such as several in Scandinavia, to afford using
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more precise techniques in their breeding and improve
their ability to compete with the large multinational
companies.
Implications of plant gene technology
policies on other national strategies
A sound use of plant gene technologies is highly relevant
to facilitate achieving the objectives of several national
sector strategies in the Scandinavian countries, such as
those related to research, food production, environmen-
tal goals, bioeconomy, sustainable agriculture etc. This
section will analyse whether or not this is reﬂected in a
number of relevant national sector strategies across the
region.
The latest position paper concerning Plant Breeding
from the Danish Ministry of Environment and Food is
named Plants for the Future. In this paper, the Ministry
states that efforts must be made to strengthen Danish
plant breeding and that public involvement in this regard
is necessary. Focused efforts will be able to contribute
to adapting agriculture to upcoming climate change and
to support the conversion of Denmark into a bio-based
society. The Ministry outlines four goals that they want
to support, i.e. (1) reduction in pesticide utilisation, (2)
breeding of varieties suitable for organic farming, (3)
breeding for improved utilisation of nitrogen and phos-
phorous and (4) development of crops and plant vari-
eties able to be included in future bioeconomy prod-
ucts (Ministeriet for Fødevarer Landbrug og Fiskeri 2014).
The details of these efforts are planned in dialogue
with the stakeholders of plant breeding in Denmark, i.e.
‘Crop Innovation Denmark’ (a public–private collabora-
tion between Danish breeders, the Danish Agriculture &
Food Council and Universities) and Organic Denmark
(an association of organic companies, organic farmers
and organic consumers). Although not mentioned in the
position paper, Plants for the Future, the use of plant gene
technologies would greatly facilitate the achievement of
several of these goals, i.e. reduction of pesticides and
increased utilisation of nitrogen and phosphorous. For
the breeding of varieties suitable for organic farming it
is, however, unlikely that plant gene technologies will
be used as organic producers are very reluctant to apply
any kind of biotechnology in their breeding programs.
In Finland, the Ministry of Agriculture and Forestry
has twice outlined a strategy for gene technology and
its implementation, ﬁrst for the period 2003–2007 and
later for 2009–2013 (Finnish Ministry of Agriculture and
Forestry 2009). The strategy was made to ensure con-
trolled implementation of gene technology to sustain via-
bility of agriculture, sustainable use of natural resources,
and production of safe and high quality goods, overall
transparent operations and efﬁcient surveillance. In the
strategy it was especially mentioned that we need to
have research to support, develop and sustain high qual-
ity expertise to be able to implement gene technology
in agriculture and forestry. In 2009, the Ministry of
Agriculture and Forestry was preparing national co-
existence regulations on the basis of the recommenda-
tion of 2003/556/EC. A Government bill 246/2009 deal-
ing with especially requirements concerning location,
pre-assessment, consent and permits of GM cultivation
was discussed in the parliament. However, this was put
on hold for several years until being currently opened
again in 2017. In 2014, a Finnish bioeconomy strategy
was outlined by the Ministries of Economic Affairs and
Employment, Agriculture and Forestry and the Environ-
ment (Finnish Bioeconomy Strategy 2014). It deﬁned four
major goals: (1) a competitive operating environment for
bioeconomy, (2) new business from the bioeconomy, (2)
a strong bioeconomy competence base and (4) accessi-
bility and sustainability for biomasses. Even though plant
breeding or gene technology were not speciﬁcally men-
tioned, it is obvious that for each one of these goals plant
biotechnology has lot to offer and plant breeding is at the
very core of a Finnish bioeconomy.
In November 2016, the Norwegian Govern-
ment presented their Bioeconomy Strategy ‘Kjente
ressurser – uante muligheter’ (Norwegian Bioecon-
omy Strategy 2016). In this strategy the government
emphasised the need of a green shift in the Norwegian
economy based on sustainable use of renewable bio-
logical resources. The bioeconomy will be developed
through investments in bio-based industry and inno-
vation, new technology and knowledge. The aim is a
sustainable, efﬁcient and proﬁtable production, harvest
and use of renewable biological resources. There is a
speciﬁc focus on the bioeconomy’s role in an environ-
mentally friendly low emission economy. Furthermore,
the Government wants to increase agricultural food pro-
duction, through rationalisation and increased research
and development on the genetic potential in plants and
animals, and through improved breeding. However,
plant gene technology is not mentioned in this regard.
Biotechnology is central in the Bioeconomy Strategy,
but generally for processing biological material for
production of high value products and not for changing
the genome of crop plants using plant gene technology.
Earlier strategies (Stortingsmeldinger) like ‘Velkommen
til bords’ (2011–2012) generally focus on the challenges
related to GMO, both ethical, regarding patent rights,
traceability, spreading etc., and not on the possibilities
this technology provides. The next Stortingsmelding
(2016) emphasised the need for plant material adapted
to Norwegian climate and the role of the Norwegian
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breeding company Graminor in this regard. Recently,
the Standing Committee on Business and Industry made
a setting to the Parliament about this ‘Stortingsmelding’
on the use of GE technology. They recommended to the
Norwegian Parliament that the new technology need
more research and must be regulated as GMOs under
the Gene Technology Act. On 26 April 2017, an unan-
imous parliament voted in support of the Committee’s
setting.
In Sweden, the recent National Food Strategy,
launched in January 2017, speciﬁcally mentioned
that novel technical innovations should be utilised in
plant breeding activities to contribute to a sustainable
production and to the adaptation of agriculture to a
changing climate (Swedish Government Ofﬁcial Report
2016/17:104). It also stated explicitly that the biosafety
assessment of novel bred cultivars should focus on the
traits, regardless of which breeding techniques have been
used in the process. We ﬁnd this highly encouraging and
in line with earlier Swedish position statements on GE
technology (see above). The Swedish position on novel
breeding techniques can also be considered relatively
appropriate for the ambitions in the National Research
Strategy for 2017 (Swedish Government Ofﬁcial Report
2016/17:50), which emphasised the importance of a
circular, bio-based economy of which the food value
chain is an integral part. The National Research Strategy
also aims to promote Sweden as a testbed and demon-
stration environment for novel technologies. As most
EU countries no longer harbour GMO ﬁeld trials, it is
therefore important that Sweden continues to allow a
continuation of research utilising GMO ﬁeld trials as
well as promotes the establishment of ﬁeld trials with
GE plants. The Swedish Government has established
16 national Environmental Objectives (Swedish Envi-
ronmental Protection Agency), and we believe gene
technologies may facilitate the work to achieve several
of these goals. To give a few examples, agriculture is
crucial for reduced climate impact, as efﬁcient breeding
for a highly productive and environmentally sustainable
crop management will contribute to climate change mit-
igation. A non-toxic environment may also, in part, be
achieved through the use of gene technologies as these
greatly facilitate the development of sustainable crop
protection while reducing the dependence on pesticides.
In this context, we ﬁnd it peculiar that Sweden recently
voted no to the authorisation in the EU of two GMmaize
events (see above), while referring to this particular
national Environmental Objective as basis for that deci-
sion, given that these GM maize events are considered
safe by EFSA and would contribute to a reduced depen-
dence on insecticides in maize cultivation. Also zero
eutrophication (through breeding for increased nutrient
use efﬁciency), a varied agricultural landscape (through
breeding to maintain culturally valuable landraces)
and a rich diversity of plant and animal life (through
breeding for reduced dependency on pesticides, and
breeding for highly productive agriculture that allows
habitat preservation) are Environmental Objectives that
also may be served by gene technologies.
There are both similarities and differences in the way
the potential beneﬁts and contributions to the society
of plant gene technologies are perceived in the Scandi-
navian countries. Norway indeed puts a lot of empha-
sis on sustainable development and use of renewable
resources, however, not more clearly acknowledging that
plant gene technologies may contribute to these goals
is from our perspective worrying. Also, the recent vote
on the authorisation of two GM maize events in the EU
shows that it is important to maintain a continuous dis-
cussion with policy makers on these matters. A recent
announcement on September 13 from the Swedish Gov-
ernment to make a large public investment in breed-
ing is highly encouraging though (Swedish Government
2017), particularly in light of the earlier statement in the
Swedish National Food Strategy that any risk assessment
of novel bred cultivars should focus on the traits.
Stakeholder opinions in the
Scandinavian countries
A reciprocal relationship between policy developments
and stakeholder opinions, including in particular the
public as a major stakeholder, is often guiding the devel-
opment of regulations as well as public R&D priorities.
Below is an outline of some of the major trends among
the stakeholder opinions in the Scandinavian countries.
A major opinion in Denmark on the use of GMO
came in 2016 when the Danish Ethical Council recog-
nised that, based on the many studies conducted on GM
crops, there are no indications it should be harmful to
eat GMO or food derived from animals fed with GMO
(Råd 2016). The use of GMO seems to be largely driven
by its application. The current Danish animal production
is dependent on cheap protein feed and two thirds of
the protein included in the feed in Danish agriculture
is imported from other countries, mainly Argentina,
Brazil and the Unites States. Around 60–90% of the
imported soybean is GM (Bosselmann et al. 2015). GM
food products are not available in Denmark. However,
studies generally conclude that the opinion on gene
technology is largely dependent on the application of
the GMO. Lassen et al. (2009) gives three parameters
that are important for the consumer’s evaluation and
acceptance of the technologies: (1) use; (2) risk and (3)
moral. The protests against GM food can largely be seen
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as a response to the fact that public regulation is focus-
ing on the handling of environmental and health risks
and not in sufﬁcient degree is covering the public con-
cerns on applications and moral/ethical considerations
(Lassen et al. 2009). In one Danish study it was inves-
tigated whether or not cisgenic crops are perceived as
more natural and more acceptable than transgenic crops
(Mielby et al. 2013). Using focus group interviews, ﬁve
lines of argument about naturalness with a bearing on
the assessment of cisgenic crops as well as GM crops
in general were identiﬁed. The study concluded that,
depending on perceptions of naturalness, some people
would agree that cisgenic crops are more acceptable
than their transgenic counterparts (Mielby et al. 2013).
In Finland, Kaljonen and Rikkonen (2004) carried out
a study of the future of multifunctional agriculture and
compared views of farmers and agri-food experts. Their
ﬁndings were that GMOs are seen as a new emerging
risk in the future, that the use of GMOs is expected to
increase and that it will have an impact on agricultural
practises. However, substantial variation was seen in the
opinions within and between the two groups ranging
fromGMO-free areas to full GMOpractises thus bringing
additional uncertainty to the development of GMOs and
their impact. Both groups believe that agricultural output
remains at the same level but radical changes are fore-
seen and depend in the case of GMOs on how the com-
mercialisation is realised. Related to the Government bill
on coexistence (249/2009), several academics signed an
appeal in 2011 to emphasise that the proposal puts cul-
tivation of EU-authorised GM varieties in a signiﬁcantly
weaker position compared to traditional or organic farm-
ing. In the appeal, it was underlined that if this proposal
would become a reality it would place GM crops and
cultivation off balance, seriously damaging the techno-
logical development, freedom of livelihood and possibil-
ities of biosciences in Finland (Hollo 2016). The Finnish
food safety authority EVIRA very clearly announces that
GM foods are safe due to the fact that prior to autho-
rization they are subject to a very thorough approval
process (Finnish Food Safety Authority 2017). Already in
2010, the advisory board on biotechnology (BTNK) pub-
lished a leaﬂet on GM foods to provide information for
consumers (Advisory Board on Biotechnology 2017) and
very clear knowledge is also available on GM and novel
foods at Ministry of Agriculture and Forestry pages (Maa-
ja metsätalousministeriö 2017).
Various stakeholders in Norway are organised in
the ‘Nettverk for GMO-fri mat og fôr’ (Network for
GMO-free food and feed), including farmer organisa-
tions, environmental organisations and food retailers.
Their agenda is to secure the consumers’ right to choose
GM-free food, feed, seeds and animals and restrictive
use of GMO both nationally and internationally. The net-
work commissioned a survey on consumer attitudes on
GM food (Bugge and Bartmann 2017). According to the
report, only 15% of Norwegian consumers are positive
to GM products in Norwegian shops, while 50% are neg-
ative. However, young people are more positive than
older people, and 31% thought GM food would be nec-
essary to feed the world in the future, while 37% did not.
The survey conﬁrms the results of a previous meta-study
ﬁnding Norwegian consumers to be among the most
sceptical towards GMO (Hess et al. 2013). In Norway
there is currently a debate on how the CRISPR tech-
nology should be regulated. Many stakeholder organi-
sations (e.g. farmer associations such as Norges Bonde-
lag, Norges Bonde- og Småbrukarlag) and NGOs (e.g.
Bellona, Greenpeace) would like the technology to be
regulated under the Gene Technology Act, whereas the
biotechnology research community are more in favour of
the technology being regulated as conventionally bred
plants in cases where no new DNA is introduced into
the crop genome. However, although the farmer organi-
sations are negative to GMO, their attitude to the newGE
technology is currently tentative, but hopeful. In contrast
to the farmer organisations in EU, Norwegian farmers
reject all use of GM feed. When it comes to genome edit-
ing, the breeding companies are taking advantage of the
attitude among Norwegian producers and are planning
to explore these techniques in future breeding programs,
particularly if the authorities conclude not to regulate GE
plants as GM, since the costs of approval is tremendous
for GM-regulated products.
The Swedish people seem, to some extent, be scepti-
cal to GM products, as was seen in a study conducted
by milk farmers where 63% of the respondents preferred
that the milk they consumed was GM-free. On the other
hand farmers support the use of the cheaper GM-based
fodder (Library of Congress 2015b). However, opinions
of people and other stakeholders on GM products based
on the surveys conducted by researchers and journal-
ists may not necessarily depict the behavioural situation
in the event when GM products are actually available
(Lusk et al. 2005). A study was conducted in several
countries, including Sweden, to depict the real-market
situation where the consumers had the possibility to pur-
chase GM products (Knight et al. 2007). Fruits labelled as
organic, conventional or spray-free GM were displayed
in road-side stall and the consumers were given the pos-
sibility to choose among the three types of fruits. When
the prices were equal, spray-free GM fruits achieved a
market share of around 20% but it soared to 43% in Swe-
denwhen the spray-free GM fruits were sold at a discount
of 15% (Knight et al. 2007). The Federation of Swedish
farmers (Lantbrukarnas Riksförbund, LRF) proposes that
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Fig. 5. Percentage of respondents who agree that GM food should be encouraged, for Denmark, Finland, Norway and Sweden. Data from
Eurobarometers 1997, 2000, 2002, 2005, 2010.
the regulations for GMO in Sweden should be updated.
GM soybean is not used in Sweden for fodder resulting in
increased expenses for purchasing conventionally grown
soybean. Almost all meat and milk products imported in
Sweden are from cattle fed with GM fodder. LRF thus
suggests that new traits in plants should be introduced for
sustainable practices irrespective of the technique used
to introduce the trait. The dairy industry in Sweden has
for many years had a policy not to use GMO as ani-
mal feed. In 2014, this policy was removed, however,
Sweden’s largest milk producer, Arla, still maintains the
policy and has decided to provide a compensation to
the Swedish dairy farmers for using non-GM fodder (Arla
2017). An investigation was carried out on the views on
biotechnology among the ﬁve actors in the Swedish food
supply chain (Björnberg et al. 2015); the two organisa-
tions that are owned by the Swedish farmers, namely LRF
and Lantmännen, and the three big food retailers ICA,
Axfood and Coop. The authors studied how these ﬁve
actors perceive the concept of agricultural sustainability
and the role of biotechnology in creating more sustain-
able agricultural production systems. In their study, LRF
was positive towards GMO in agriculture if it contributed
positively both environmentally and economically with-
out affecting the human and animal health negatively.
According to the study, Lantmännen acknowledges the
potential of biotechnology for sustainable agriculture;
however, they adopt a precautionary principle and is also
based on the demands and requirements of their cus-
tomers as well as the overall opinion in their market(s).
Among the three big retailers, ICA and Axfood do not
have a cohesive policy towards GMO and considers it
important to label the GM-based products appropriately,
while Coop believes that GMO might have a negative
impact both on the environment and the farmers. None
of the three retailers sell any products containing GM
ingredients (Björnberg et al. 2015).
It is challenging to compare the stakeholder and pub-
lic attitudes to plant gene technologies among the four
Scandinavian countries, as most studies have different
scopes and setups. For comparative data on public opin-
ions, the regular Eurobarometer gives useful long-term
information. When looking at the data for the Scandi-
navian countries from the Eurobarometers from 1997,
2000, 2002, 2005 and 2010 (including Norway for 1996
and 1999), we see that the percentage of respondents
who are in favour of GM food applications have been
similar, at a rather low level of 25–40%, for Denmark,
Norway and Sweden over the period. Finland on the
other hand had a much higher public support early in
the period but has seen a steady decrease down to the
level of the other countries (Fig. 5) (Eurobarometer 1997,
2000, 2002, 2005, 2010).
Discussion and future perspectives
The Scandinavian region, situated in the European high
north, is not only unique concerning climate, temper-
ature and daylight, but also regarding speciﬁc regu-
lations of fertiliser and pesticide uses. Crops speciﬁ-
cally adapted to these conditions have been developed
for many decades through the ongoing efforts of pub-
lic plant breeding programmes as well as small- and
medium-size breeding companies concentrating their
efforts especially for these conditions (Andersen et al.
2013, Nilsson et al. 2016). However, the current global
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trend of concentrating breeding companies into large
multinational entities focusing on major crops and large
markets potentially poses a challenge for the develop-
ment of crops well adapted to the unique climate of the
Scandinavian countries. It is therefore essential that plant
breeding efforts speciﬁcally for this part of the world
continue in order to meet the common goals within the
Scandinavian countries of a sustainable agriculture with
reduction of its environmental footprints, i.e. reduction
of pesticides and an efﬁcient use of fertiliser. An addi-
tional and highly relevant challenge in the coming years
is that the global warming is expected to raise the average
temperature with 1–1.5∘C over the next 50 years. A pro-
longed growth season and change in the rainfall pattern
in Scandinavia is expected to lead to increased stress and
pressure from diseases and pests. These problems can
only be solved through plant breeding to speciﬁc areas.
However, breeding of crops is a long and competitive
process, and plant gene technologies are considered key
elements for future successful breeding.
The European continent is often depicted as being
politically highly restrictive to the application of plant
gene technology, including GMO. However, in reality
there is large variation among the countries regarding
the policies and political attitudes to plant gene technol-
ogy. About 8–10 countries (of EU-28) can be described
as highly restrictive whereas another 8–10 actually
have a rather permissive attitude to GM applications.
Of the Scandinavian EU Member States, Denmark is
the only one that has implemented the Directive (EU)
2015/412 and requested that the Danish territory should
be excluded from authorization to cultivate the GM
maize events MON810, 1507, Bt11 and GA21. It makes
sense that the other Scandinavian countries have not
delivered similar requests, as the GM events in question
are not relevant to agriculture in the far north of Europe.
It will be interesting though to follow the development in
the other Scandinavian countries regarding the Directive
(EU) 2015/412, if other GM events eventually reach
the market. The regular voting behaviour in the EU
gives general indications to the political attitudes to
plant gene technology. A study from 2015 by EuropaBio
(EuropaBio 2015) indicated that Denmark and Sweden
tended to vote according to the scientiﬁc advice for
GM applications in 2014, though perhaps not in every
instant, and Finland is among the group of about 10
EU countries who always followed science in their
votings in 2014. Mühlböck and Tosun (2015) analysed
the voting behaviour for GM events in the EC over the
period 2004–2014 and found that Sweden and Finland
are among the most permissive countries with nearly
100% of the votes in favour of GM approval, whereas
Denmark is found somewhere in the middle of the
EU-28 list with about 60% of votes in favour and about
40% of votes against GM event authorizations. Also, a
study by Smart et al. (2015) of the EU Member States’
voting behaviour on GM events in 2003–2015 conﬁrms
this general picture. According to this study, Finland was
the only country that voted in favour of authorisation of
GM crops for food and feed use every time (under Reg-
ulation 1829/2003) in the Standing Committee on the
Food Chain and Animal Health (SCFCAH), and nearly
every time in the Appeal Committee (AC), in the years
2003–2015. Sweden is not far behindwith 54 (of 61) and
50 (of 57) of the votes in the SCFCAH and the AC, respec-
tively, in favour of authorisation. Denmark has a slightly
less favourable voting record though, with 38 respective
34 votes in favour in these committees (Fig. 6); however,
in an EU-28 context this is still relatively complaisant to
the EFSA evaluations. A notable exception to the trend of
Sweden to follow the scientiﬁc advice provided by EFSA
occurred in the latest votes on 27 January 2017 in the
Regulatory Committee (under Directive 2001/18/EC) and
27March 2017 (Appeal Committee) when Sweden voted
against authorisation for cultivation of two maize events
(Bt11 and 1507) that are insect-resistant and herbicide
(gluphosinate ammonium)-tolerant (AGRA FACTS 2017;
Greenpeace European Unit 2017). According to the
Swedish Minister of the Environment, Karolina Skoog,
this was because cultivation of these two maize events
is considered to be in conﬂict with one of the Swedish
Environmental Objectives (Swedish Environmental Pro-
tection Agency), namely A non-toxic environment. It
goes beyond the scope of this article to analyse in fur-
ther detail all the reasons for this voting pattern among
the Scandinavian countries; however, we do notice an
overall tendency among the Scandinavian countries, in
particular perhaps Finland and Sweden, to represent
an innovation-friendly and scientiﬁcally motivated atti-
tude towards plant gene technology (Fig. 6), when seen
against a European background.
Also for stakeholder/public opinions about plant gene
technology, there is large variation among European
countries. Even though national surveys in, e.g. Norway
(Bugge and Bartmann 2017) (Hess et al. 2013) indicate
that many people are negative to plant gene technol-
ogy, a closer look at the most recent Eurobarometer on
Biotechnology, which is from 2010, shows that people
from Denmark, Finland, Norway and Sweden tend to be
slightly less negative to GM food in comparison to many
other European countries, though the level of respon-
dents being in favour of GM food is still rather low. The
awareness of the technology is nevertheless often high
across these four countries, with 87–96% of the respon-
dents having heard about GM food. The attitudes towards
GM food tend to be slightly more positive than the EU-27
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Fig. 6. Voting pattern of Denmark, Finland and Sweden on GMO authorizations at the Standing Committee on the Food Chain and Animal Health
(SCFCAH) from December 2003 to December 2014 and at the Council/Appeal Committee from May 2004 to February 2015. Data adopted from
Smart et al. (2015). F, for; A, against; O, abstain. SCFCAH, Standing Committee on the Food Chain and Animal Health; C/AC, Commission/Appeal
Committee.
(as of 2010) average, here with Denmark at the higher
range whereas Sweden would for a few of the questions
have slightly more negative responses (European Com-
mission 2010). Even though it is difﬁcult to ascertain
whether or not the national policies on plant gene tech-
nology in the Scandinavian countries reﬂect the public
and/or other stakeholder opinions – or vice versa – at
least there appears to be no apparent conﬂict between
the two.
The Scandinavian region is unique in several aspects.
At the same time the relatively small market sizes of the
countries in this region may act as a limiting factor to pri-
vate investments in regionally adapted breeding. Apart
from the importance of substantial and long-term stable
public investments, it is therefore also imperative to
discuss the role and regulation of innovative solutions in
Scandinavian plant research and breeding. All Scandina-
vian countries position themselves relatively well in the
overall strategies to develop sustainable bioeconomies
in Europe, and most of them have recently also adopted
a national bioeconomy strategy. However, strategy is
nothing without a clear implementation plan. It is impor-
tant that all Scandinavian countries quickly get new
bio-based entrepreneurship running to fully exploit the
growth possibilities of a bioeconomy. Plant gene technol-
ogy is deﬁnitely contributing to these growth prospects.
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